Sulcoflex. For when perfection is the only option! Pseudophakic Sulcus Fixated Secondary IOLs. Sulcoflex Aspheric. Sulcoflex Toric

Size: px

Start display at page:

Download "Sulcoflex. For when perfection is the only option! Pseudophakic Sulcus Fixated Secondary IOLs. Sulcoflex Aspheric. Sulcoflex Toric"

Jordan Blake
5 years ago
Views:

1 Sulcoflex Pseudophakic Sulcus Fixated Secondary IOLs Sulcoflex Aspheric Sulcoflex Toric Sulcoflex Multifocal For when perfection is the only option!

2 Sulcoflex Pseudophakic Sulcus Fixated Secondary IOLs HYDROPHILIC ACRYLIC INJECTABLE IOLs WITH UNDULATING HAPTICS AND POSTERIOR HAPTIC ANGULATION With advanced IOL design and modern surgical technique, an exact refractive result following cataract surgery with implantation of an IOL is a reasonable expectation. Rayner Sulcoflex Pseudophakic Sulcus Fixated Secondary IOLs are designed to be implanted in the ciliary sulcus to correct any residual postoperative refractive errors following the primary implantation of a conventional IOL in the capsular bag. For optimum optical performance, Rayner Sulcoflex Pseudophakic Sulcus Fixated Secondary IOLs incorporate Rayner s aberration-neutral aspheric optic technology as standard. Sulcoflex Pseudophakic Sulcus Fixated Secondary IOLs are available as: Sulcoflex Aspheric - for the correction of any residual pseudophakic ametropia. Sulcoflex Toric - for the correction of any residual pseudophakic corneal astigmatism. Sulcoflex Multifocal - for the correction of pseudophakic presbyopia. Indications 1 Post-surgical ametropia. Enhancement of the refractive result after RLE or PRELEX. Enhancement of near / far vision. Correction of any residual corneal astigmatism. Correction of refractive changes following paediatric implantation. Enhancement of monovision.

3 Reduces the surgical risk associated with an IOL exchange 1 Implanting a Sulcoflex Pseudophakic Sulcus Fixated Secondary IOL in the ciliary sulcus can be an easier surgical option than performing an IOL exchange, especially when capsular changes may have firmly fixated the primary implant within the capsular bag. Avoids the potential problems of conventional piggy-back IOLs 1 Unlike conventional piggy-back IOL implantations, the unique design of Sulcoflex Pseudophakic Sulcus Fixated Secondary IOLs reduces the likelihood of induced refractive error and optical aberrations due to optic surface distortion at the area of contact between the two IOLs. This is achieved by Sulcoflex IOLs having a concave posterior surface, which minimises the possibility of any physical contact. Similarly, the implantation of a second conventional biconvex IOL in the ciliary sulcus can sometimes be associated with Pigment Dispersion Syndrome (PDS), or interlenticular opacification. The unique design of Sulcoflex Pseudophakic Sulcus Fixated Secondary IOLs ensures that the occurrence of such unwanted complications is minimised. Sulcoflex Pseudophakic Sulcus Fixated Secondary IOLs incorporate several novel design features, which significantly contribute to refractive performance. Aberration-neutral Aspheric Optics Reduced loss of contrast sensitivity. Increased functional visual acuity. Large optic diameter (6.5mm) Optimises the visual outcome. Reduces the risk of optic-iris capture. Reduces the risk of edge glare and associated dysphotopsia. Undulating haptics (13.50mm overall length) Excellent centration and stability. 1 Good uveal clearance. 1 Avoids pigment dispersion. 1

Soft, round-edged haptics Minimum tissue reaction. 1 Manufactured from Rayacryl the ideal IOL biomaterial Exceptional uveal biocompatibility Especially important for ciliary sulcus fixation.

Sulcoflex Aspheric Sulcoflex Aspheric IOLs are indicated for the correction of any residual pseudophakic ametropia. With the Standard dioptric range from 5.0D to +5.

4 Soft, round-edged haptics Minimum tissue reaction. 1 Manufactured from Rayacryl the ideal IOL biomaterial Exceptional uveal biocompatibility Especially important for ciliary sulcus fixation. 2,3 Superb optical clarity No vacuoles or glistenings. Remarkably low silicone oil adherence. Non bioadhesive Does not adhere to adjacent anatomical structures. Easy to inject. Sulcoflex Aspheric Sulcoflex Aspheric IOLs are indicated for the correction of any residual pseudophakic ametropia. With the Standard dioptric range from 5.0D to +5.0D and the Premium dioptric range extending from 10.0D to +10.0D, Sulcoflex Aspheric IOLs offer an effective, cost advantageous and safer option for the resolution of post-operative myopic or hypermetropic refractive surprises.

Sulcoflex Toric Sulcoflex Toric IOLs are indicated for the correction of any residual pseudophakic corneal astigmatism.

and the unique undulating haptic design ensures exceptional rotational stability leading to precise toric corrections.

$the use of spectacles or contact lenses. Based on Rayner s refractive aspheric optic technology, near vision is achieved by the addition of +3.$

5 Sulcoflex Toric Sulcoflex Toric IOLs are indicated for the correction of any residual pseudophakic corneal astigmatism. The implantation of a Sulcoflex Toric IOL offers a precise and reliable alternative to corneal surgery and is available in a range of sphere / cylinder combinations.and the unique undulating haptic design ensures exceptional rotational stability leading to precise toric corrections. Sulcoflex Multifocal Sulcoflex Multifocal IOLs are indicated for the correction of pseudophakic presbyopia, thereby significantly reducing the need for additional near correction by the use of spectacles or contact lenses. Based on Rayner s refractive aspheric optic technology, near vision is achieved by the addition of +3.5D at the IOL plane in a far dominant format. With its carefully calculated combination of refractive power and aspheric design, the Sulcoflex Multifocal IOLs are associated with excellent visual outcomes, with a remarkably low incidence of halos and glare and, compared with conventional diffractive multifocal IOLs, significantly less loss of contrast sensitivity.

6 Implantation Implantation is both easy and precise through a sub 3.0mm incision using the Rayner Single Use Soft-Tipped Injector. The Rayner Single Use Soft-Tipped Injector offers: Convenience Safety Cost effectiveness Controlled and safe unfolding of the IOL within the eye. Physical parameters Optic Body diameter Overall length Haptic angulation Configuration 6.5mm 13.5mm 10º Anterior Convex, Posterior Concave Power Availability Sulcoflex Aspheric (653L) Standard range -5.0D to +5.0D in 0.5D increments * Premium range -10.0D to -5.5D in 0.5D increments +5.5D to +10.0D in 0.5D increments Sulcoflex Multifocal (653F) -3.0D to +3.0D in 0.5D increments with +3.5D add Sulcoflex Toric (653T) Standard range SE 3.0D to +3.0D in 0.5D steps, cylinder +1D to +3D in 1.0D steps Cylinder 1.0D 2.0D 3.0D Minimum sphere -3.5D -4.0D -4.5D Maximum sphere +2.5D +2.0D +1.5D

7 * Premium range SE 6.0D to +6.0D in 0.5D steps, cylinder +1D to +6D in 0.5D steps Cylinder 1.0D 1.5D 2.0D 2.5D 3.0D 3.5D 4.0D 4.5D 5.0D 5.5D 6.0D Minimum sphere -6.5D -6.5D -7.0D -7.0D -7.5D -7.5D -8.0D -8.0D -8.5D -8.5D -9.0D Maximum sphere +5.5D +5.0D +5.0D +4.5D +4.5D +4.0D +4.0D +3.5D +3.5D +3.0D +3.0D * Manufactured specifically to order. Presentation Rayner Sulcoflex Pseudophakic IOLs are supplied in 0.9% saline solution in a pouched blister pack, sterilised by moist heat and presented in a convenient, ready to use Lens Injection System Pack containing: One Sulcoflex Pseudophakic Sulcus Fixated Secondary IOL. One Rayner Single Use Soft-Tipped injector.

8 References 1. Sulcoflex (Rayner 653L) a new IOL for implantation in the pseudophakic eye: Indications and first results. M. Amon, G. Kahraman, J. Schauersberger, Vienna, Austria Presented at ESCRS, Stockholm, Sweden, Capsular and uveal biocompatibility at three years following hydrophilic lens implantation in eyes with uveitis history photographic assessment A. Vyas, D. Spokes, R. Narendran, P. Bacon Scarborough Hospital, UK Presented at ESCRS, Stockholm, Comparison of the uveal and capsular biocompatibility of the Rayner Centerflex (570H) vs. Rayner C-flex (570C) three year results G. Kahraman, M. Amon, C. Abela-Formanek, G. Schild-Burggasser, J. Schauerberger Vienna, Austria Presented at ESCRS, Stockholm, Sulcoflex Pseudophakic Sulcus Fixated Secondary IOLs have been designed in collaboration with Professor Michael Amon, Vienna, Austria. Note: Sulcoflex IOLs are not yet approved by the US FDA and Canadian authorities. 11/08 Copyright Rayner Intraocular Lenses Limited Unauthorised reproduction prohibited.

Product Portfolio. Sulcoflex Pseudophakic Supplementary IOLs. Your skill. Our vision.

Product Portfolio. Sulcoflex Pseudophakic Supplementary IOLs. Your skill. Our vision. Product Portfolio Sulcoflex Pseudophakic Supplementary IOLs Your skill. Our vision. Sulcoflex Pseudophakic Supplementary IOLs For when compromise is not an option As a cataract and refractive surgeon,